Replies to post #2479 on Onconova Therapeutics Inc (ONTX)

[pb_trading]

ONTX upgraded and rated a buy across the board.

Brokerage Action Rating Price Target Impact on Share Price Details
5/15/2020 Maxim Group Upgrade Hold --> Buy High
3/25/2020 HC Wainwright Reiterated Rating Buy High
12/27/2019 Noble Financial Reiterated Rating Buy $1.30 High
7/25/2017 Dawson James Reiterated Rating Buy High
(Data available from 5/15/2018 forward)

ONCONOVA THERAPEUTICS (NASDAQ:ONTX) PRICE TARGET AND CONSENSUS RATING
3 Wall Street analysts have issued ratings and price targets for Onconova Therapeutics in the last 12 months. Their average twelve-month price target is $4.65, suggesting that the stock has a possible upside of 1,191.67%. The high price target for ONTX is $8.00 and the low price target for ONTX is $1.30. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."

https://www.marketbeat.com/stocks/NASDAQ/ONTX/price-target/

$ONTX